Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

Hepatology

Volumn 42, Issue 6, 2005, Pages 1437-1445

  Zeng, Min De ^a   Lu, Lun Gen ^a   Mao, Yi Min ^a   Qiu, De Kai ^a   Li, Ji Qiang ^a   Wan, Mo Bin ^b   Chen, Cheng Wei ^c   Wang, Ji Yao ^d   Cai, Xiong ^e   Gao, Chun Fang ^e   Zhou, Xia Qiu ^f  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Research Center for Hepatic Diseases   (China)

^d FUDAN UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; HYALURONIC ACID;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; AREA UNDER CURVE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 32944480725     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20960     Document Type: Article

References (30)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
2. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). HEPATOLOGY 2000;32:477-481.
3. Freidman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003;38:S38-S53.
4. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174.
5. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. HEPATOLOGY 2002;36:986-992.
6. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.
7. Scheuer PJ. The nomenclature of chronic hepatitis: time for a change. J Hepatol 1995;22:112-114.
8. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
9. Hui AY, Chan HLY, Wong VWS, Liew CT, Chim AML, Chan FKL, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-623.
10. Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Curr Pharm Biotechnol 2003;4:195-209.
11. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? HEPATOLOGY 2003;37:972-974.
12. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-230.
13. Masseroli M, Caballero T, O'Valle F, Del Moral RMG, Perez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000;32:453-464.
14. Fontana RJ, Lok ASF. Noninvasive monitoring of patients with chronic hepatitis C. HEPATOLOGY 2002;36:S57-S64.
15. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero J, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003;38:518-526.
16. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis: Diagnostic interest. Dig Dis Sci 1994;39:2426-2432.
17. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-1116.
18. Patel K, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-942.
19. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 2002;97:2419-2425.
20. Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol 1999;14(Suppl):S1-S5.
21. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003;38:257-265.
22. Poynard T, Bedossa P, METAVIR and CLINIVIR Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepatol 1997;4:199-208.
23. Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Cresta E, et al. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of northern Italian patients. Liver 1999;19:432-437.
24. Guechot J, Serfaty L, Bonnand AM, Chazouilleres O, Poupon E, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000;32:447-452.
25. Rosenberg WMC, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-1713.
26. Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406.
27. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996;42:558-563.
28. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000;24:626-630.
29. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344-1355.
30. Imbert-Bismut F, Messous D, Thibault V, Myers RB, Piton A, Thabut D, et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med 2004;42:323-333.